FDA Investigator Tammara A Stephens
Tammara A Stephens has inspections in 2 countries as of 29 Aug 2023. Tammara A Stephens has collaborated with a combinined 2467 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
A Williams,
Adam R Cooke,
Amy H Ruble,
Arie C Menachem,
Babatunde D Babalola,
Barbara M Frazier,
Barbara T Carmichael,
Billy M Battles,
Bonita S Chester,
Brandon C Heitmeier,
Brandy D Brown,
Brentley S Collins,
Brooke K Higgins,
Burnell M Henry,
Calvin Foulks,
Carlos M Gonzalez,
CDR Ileana Barreto Pettit,
CDR Thomas R Berry, PPh,
Cherrie A Zachary,
Cherry R Valerio,
Christian D Lynch (CDL),
Christie A Beatty,
Christie B Rice,
Christopher B May,
Claire M Minden,
Claudette D Brooks,
Cordelia J Brammer,
Cynthia Jim, CSO,
Daphne Santiago, PhD,
David J Gomes,
Dawn M Braswell,
Dellarese L Herbert,
Denise M Digiulio,
Dennis Cantellops Paite,
Derek C Price,
Devaugh Edwards,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Edward Deberry,
Edward H Maticka,
Eliezar Ramos,
Erin C Hill,
Fulton A Varner,
Gabriel R Mclemore,
Gamal A Norton,
George J Flynn,
Geraldine D Sanders,
Geraldine Sanders,
Gideon N Esuzor,
Hector A Carrero,
Helen R Bester,
Ibad U Khan,
Inga M Warr,
Jacqueline Mdiaz Albertini,
Jared P Stevens,
Jason F Chancey,
Jawaid Hamid,
Jennifer D Hollstrom,
Jennifer L Bridgewater,
Jennifer Lalama,
Joanne E King,
Joseph F Owens,
Julie D Bringger,
Justin A Boyd,
Karen A Coleman,
Karen Gale Sego,
Kathleen D Culver,
Katrina B Mosley Sloan,
Kimberly Cdelk Brooks,
Kip J Hanks,
Laiza V Garcia,
Larry K Hampton,
Latonya T Jiggetts,
Lawrence Carter, III,
Lesley K Satterwhite,
Leslie W Gilbert,
LT Tamara J Henderson,
Marc A Alston,
Marian A Kainer,
Marie F Morin,
Marisa E Stock,
Marvin D Jones,
Mary A Millner,
Mary Alice Papdimitriou,
Melanie M Walker,
Miaja Umaedi,
Michele L Forster, PhD,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Monica Cburgos Garcia,
Myoshi M Francis,
Nancy G Schmidt,
Nydia E Colon,
Omotunde O Osunsanmi,
Pal S Mayasandra,
Patricia D Stahnke,
Patricia F Hudson,
Paul A Bonneau,
Penny H Mccarver,
Perry H Gambrell,
Phillip M Pontikos,
Prabhu P Raju,
R Edwadebey Deberry,
Randy L Clarida,
Regina T Brown,
Rhonda Alexander,
Robert C Coleman,
Ronnie E Jackson,
Rose M Ashley,
Rozelle G Smith,
Samantha J Bradley,
Samuel L Murray,
Sayeeda Hdabe,
Seneca D Toms,
Sixto M Mercado Rios,
Sonya M Edmonds,
Stephanie E Hubbard,
Stephen D Brown,
Steven C Madzo,
Steven D Dittert,
Tamara M Casselman,
Tamara M Felton,
Tamika D Cathey,
Tammara A Newberry,
Thomas J Arista,
Thomas R Withers,
Trang N Cox,
Trang P Nguyen,
Travis E Chapman,
Vanessa E Coulter,
Vicky C Stoakes,
Vincent M Williams,
Viviana Matta,
Xiomara Copeland,
Yun Wu, PhD,
Zhong Li, PhD
Tammara A Stephens's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2005 | EIR | Greer Laboratories, Inc. - EIR, 2005-03-03 |
| September, 2014 | EIR | Patheon Manufacturing Services LLC - EIR, 2014-09-12 |
| March, 2013 | FDA 483 | Hospira, Inc. - Form 483, 2013-03-01 |
| October, 2012 | FDA 483 | Artivion, Inc - Form 483, 2012-10-16 |
| March, 2014 | FDA 483 Response | Artivion, Inc - Form 483R, 2014-04-10 |
| June, 2010 | FDA 483 | Bausch & Lomb Incorporated - Form 483, 2010-06-25 |
| March, 2014 | FDA 483 | Artivion, Inc - Form 483, 2014-03-20 |
| June, 2014 | EIR | Hospira, Inc. - EIR, 2014-06-13 |
| March, 2005 | FDA 483 | Greer Laboratories, Inc. - Form 483, 2005-03-03 |
| May, 2009 | FDA 483 | Cardinal Health 414, LLC - Form 483, 2009-05-15 |
| August, 2007 | FDA 483 | Qualitest Pharmaceuticals - Form 483, 2007-08-08 |
| September, 2014 | FDA 483 | Patheon Manufacturing Services LLC - Form 483, 2014-09-12 |
| August, 2005 | FDA 483 | Artivion, Inc - Form 483, 2005-08-05 |
| March, 2013 | EIR | Hospira, Inc. - EIR, 2013-03-01 |
| August, 2018 | FDA 483 | Artivion, Inc - Form 483, 2018-08-08 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more